{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:19:29Z","timestamp":1793974769222,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhanjiang Science and Technology Project","award":["2025A504001"],"award-info":[{"award-number":["2025A504001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52394-x","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:47:03Z","timestamp":1778662023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MRI-based habitat and peritumoral radiomics for predicting HER2 status in breast cancer: a multicenter study"],"prefix":"10.1038","volume":"16","author":[{"given":"Wenxuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"52394_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang, Y., Zhang, H. & Song, X. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 60, 14\u201327 (2020).","journal-title":"Semin Cancer Biol."},{"issue":"23","key":"52394_CR2","doi-asserted-by":"publisher","first-page":"14937","DOI":"10.3390\/ijms232314937","volume":"23","author":"E Kudelova","year":"2022","unstructured":"Kudelova, E., Smolar, M. & Holubekova, V. Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer. Int. J. Mol. Sci. 23 (23), 14937 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"52394_CR3","first-page":"653","volume":"74","author":"A Roulot","year":"2016","unstructured":"Roulot, A., H\u00e9quet, D. & Guinebreti\u00e8re, J. M. Tumoral heterogeneity of breast cancer. Ann. Biol. Clin. (Paris). 74, 653\u2013660 (2016).","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"52394_CR4","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","volume":"24","author":"A Prat","year":"2015","unstructured":"Prat, A., Pineda, E. & Adamo, B. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast 24, S26\u2013S35 (2015).","journal-title":"Breast"},{"key":"52394_CR5","first-page":"8008","volume":"8","author":"W Guo","year":"2015","unstructured":"Guo, W. et al. HER2 status in molecular apocrine breast cancer: Associations with clinical, pathological, and molecular features. Int. J. Clin. Exp. Pathol. 8, 8008\u20138017 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"52394_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.humpath.2020.01.003","volume":"98","author":"JW Woo","year":"2020","unstructured":"Woo, J. W. et al. The updated 2018 American Society of Clinical Oncology\/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: Comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups. Hum. Pathol. 98, 10\u201321 (2020).","journal-title":"Hum. Pathol."},{"key":"52394_CR7","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","volume":"391","author":"A Bardia","year":"2024","unstructured":"Bardia, A., Hu, X. & Dent, R. Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer. N Engl. J. Med. 391, 2110\u20132122 (2024).","journal-title":"N Engl. J. Med."},{"key":"52394_CR8","doi-asserted-by":"publisher","first-page":"e232047","DOI":"10.1148\/radiol.232047","volume":"309","author":"X Zhang","year":"2023","unstructured":"Zhang, X., Su, G. H., Chen, Y., Gu, Y. J. & You, C. Decoding intratumor heterogeneity: Clinical potential of habitat imaging based on Radiomics. Radiology 309, e232047 (2023).","journal-title":"Radiology"},{"key":"52394_CR9","doi-asserted-by":"publisher","first-page":"102443","DOI":"10.1016\/j.compmedimag.2024.102443","volume":"118","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy. Comput. Med. Imaging Graph. 118, 102443 (2024).","journal-title":"Comput. Med. Imaging Graph"},{"key":"52394_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40644-024-00758-9","volume":"24","author":"S Li","year":"2024","unstructured":"Li, S., Dai, Y., Chen, J., Yan, F. & Yang, Y. MRI-based habitat imaging in cancer treatment: Current technology, applications, and challenges. Cancer Imaging. 24, 107 (2024).","journal-title":"Cancer Imaging"},{"key":"52394_CR11","first-page":"15877","volume":"14","author":"J Wu","year":"2024","unstructured":"Wu, J., Meng, H. & Zhou, L. Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: A multicenter study. Front. Oncol. 14, 15877 (2024).","journal-title":"Front. Oncol."},{"key":"52394_CR12","doi-asserted-by":"publisher","first-page":"1252074","DOI":"10.3389\/fonc.2023.1252074","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang, S., Liu, X. & Wu, Y. Habitat-based radiomics enhances the ability to predict lymphovascular space invasion in cervical cancer: A multi-center study. Front. Oncol. 13, 1252074 (2023).","journal-title":"Front. Oncol."},{"key":"52394_CR13","doi-asserted-by":"publisher","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi, Z., Huang, X. & Cheng, Z. MRI-based quantification of intratumor heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 308, e222830 (2023).","journal-title":"Radiology"},{"key":"52394_CR14","doi-asserted-by":"publisher","first-page":"e241805","DOI":"10.1148\/radiol.241805","volume":"315","author":"Y Huang","year":"2025","unstructured":"Huang, Y., Wang, X. & Cao, Y. Nomogram for predicting neoadjuvant chemotherapy response in breast cancer using mri-based intratumor heterogeneity quantification. Radiology 315, e241805 (2025).","journal-title":"Radiology"},{"key":"52394_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen, H., Liu, Y. & Zhao, J. Quantification of intratumor heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and-zero breast cancers: A multicenter study. Breast Cancer Res. 26, 160 (2024).","journal-title":"Breast Cancer Res."},{"key":"52394_CR16","doi-asserted-by":"publisher","first-page":"e28722","DOI":"10.1016\/j.heliyon.2024.e28722","volume":"10","author":"J Zhou","year":"2024","unstructured":"Zhou, J., Yu, X. & Wu, Q. Radiomics analysis of intratumor and different peritumor regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study. Heliyon 10, e28722 (2024).","journal-title":"Heliyon"},{"key":"52394_CR17","doi-asserted-by":"publisher","first-page":"102963","DOI":"10.1016\/j.ebiom.2020.102963","volume":"59","author":"S Roy","year":"2020","unstructured":"Roy, S. et al. Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging. EBioMedicine 59, 102963 (2020).","journal-title":"EBioMedicine"},{"issue":"8","key":"52394_CR18","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1007\/s00330-020-07598-8","volume":"31","author":"L Fournier","year":"2021","unstructured":"Fournier, L. et al. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers. Eur. Radiol. 31 (8), 6001\u20136012 (2021).","journal-title":"Eur. Radiol."},{"issue":"10","key":"52394_CR19","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.21037\/tcr-22-1626","volume":"11","author":"C Ladbury","year":"2022","unstructured":"Ladbury, C., Zarinshenas, R. & Semwal, H. Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: A narrative review. Translational Cancer Res. 11 (10), 3853\u20133868 (2022).","journal-title":"Translational Cancer Res."},{"key":"52394_CR20","doi-asserted-by":"publisher","first-page":"e38082","DOI":"10.2196\/38082","volume":"24","author":"J Li","year":"2022","unstructured":"Li, J. et al. Predicting mortality in intensive care unit patients with heart failure using an interpretable machine learning model: Retrospective cohort study. J. Med. Internet Res. 24, e38082 (2022).","journal-title":"J. Med. Internet Res."},{"key":"52394_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/s41379-019-0295-8","volume":"32","author":"S Zare","year":"2019","unstructured":"Zare, S., Rong, J. & Daehne, S. Implementation of the 2018 American Society of Clinical Oncology\/College of American Pathologists Guidelines on HER2\/neu Assessment by FISH in breast cancers: predicted impact in a single institutional cohort. Mod. Pathol. 32, 1566\u20131573 (2019).","journal-title":"Mod. Pathol."},{"issue":"6","key":"52394_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12282-023-01488-9","volume":"30","author":"ST Chen","year":"2023","unstructured":"Chen, S. T., Lai, H. W. & Chang, J. H. Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: Variations in intrinsic subtypes, and strategy to improve negative predictive value-an analysis of 2473 invasive breast cancer patients. Breast Cancer. 30 (6), 976\u2013985 (2023).","journal-title":"Breast Cancer"},{"key":"52394_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s41747-022-00289-7","volume":"6","author":"F Galati","year":"2022","unstructured":"Galati, F., Rizzo, V. & Moffa, G. Radiologic-pathologic correlation in breast cancer: Do MRI biomarkers correlate with pathologic features and molecular subtypes? Eur. Radiol. Experimental. 6, 39 (2022).","journal-title":"Eur. Radiol. Experimental"},{"issue":"1","key":"52394_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40644-024-00758-9","volume":"24","author":"S Li","year":"2024","unstructured":"Li, S., Dai, Y. & Chen, J. MRI-based habitat imaging in cancer treatment: Current technology, applications, and challenges. Cancer Imaging. 24 (1), 107 (2024).","journal-title":"Cancer Imaging"},{"key":"52394_CR25","first-page":"957","volume":"16","author":"Y Shang","year":"2024","unstructured":"Shang, Y., Wang, Y. & Guo, Y. The clinical study of intratumor and peritumor radiomics based on DCE-MRI for HER-2 positive and low expression prediction in breast cancer. Breast Cancer (Dove Med. Press). 16, 957\u2013972 (2024).","journal-title":"Breast Cancer (Dove Med. Press)"},{"issue":"10","key":"52394_CR26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41416-024-02871-9","volume":"131","author":"S Wang","year":"2024","unstructured":"Wang, S., Wang, T. & Guo, S. Whole tumour- and subregion-based radiomics of contrast-enhanced mammography in differentiating HER2 expression status of invasive breast cancers: A double-centre pilot study. Br. J. Cancer. 131 (10), 1613\u20131622 (2024).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"52394_CR27","doi-asserted-by":"publisher","first-page":"14720","DOI":"10.1038\/s41598-025-98155-0","volume":"15","author":"H Xu","year":"2025","unstructured":"Xu, H. et al. Intratumoral and peritumoral radiomics signature based on DCE-MRI can distinguish between luminal and non-luminal breast cancer molecular subtypes. Sci. Rep. 15 (1), 14720 (2025).","journal-title":"Sci. Rep."},{"issue":"9","key":"52394_CR28","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.21037\/qims-24-976","volume":"15","author":"H Luo","year":"2025","unstructured":"Luo, H. et al. Development of a prediction model for HER2 low breast cancer using quantitative intra- and peri-tumoral heterogeneity and MRI features on high-spatial resolution ultrafast DCE-MRI. Quant. imaging Med. Surg. 15 (9), 7788\u20137802 (2025).","journal-title":"Quant. imaging Med. Surg."},{"issue":"1","key":"52394_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-024-01921-7","volume":"26","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Quantification of intratumoral heterogeneity using habitat-based MRI radiomics to identify HER2-positive, -low and -zero breast cancers: A multicenter study. Breast Cancer Res. 26 (1), 160 (2024).","journal-title":"Breast Cancer Res."},{"key":"52394_CR30","doi-asserted-by":"publisher","first-page":"9623173","DOI":"10.1155\/2022\/9623173","volume":"2022","author":"T Du","year":"2022","unstructured":"Du, T. & Zhao, H. Habitat analysis of breast cancer-enhanced MRI reflects BRCA1 mutation determined by immunohistochemistry. Biomed. Res. Int. 2022, 9623173 (2022).","journal-title":"Biomed. Res. Int."},{"key":"52394_CR31","doi-asserted-by":"crossref","unstructured":"Kazerouni, A. S. et al. Quantifying tumor heterogeneity via MRI habitats to characterize microenvironmental alterations in HER2 + breast cancer. Cancers (Basel) 14(7), 1837 (2022).","DOI":"10.3390\/cancers14071837"},{"key":"52394_CR32","doi-asserted-by":"publisher","first-page":"102470","DOI":"10.1016\/j.media.2022.102470","volume":"79","author":"BHM n der Velden","year":"2022","unstructured":"n der Velden, B. H. M., Kuijf, H. J., Gilhuijs, K. G. A., Viergever, M. A. & va,, Explainable artificial intelligence (XAI) in deep learning-based medical image analysis. Med. Image Anal. 79, 102470 (2022).","journal-title":"Med. Image Anal."},{"key":"52394_CR33","doi-asserted-by":"publisher","first-page":"1180773","DOI":"10.3389\/fmed.2023.1180773","volume":"10","author":"BM Vries","year":"2023","unstructured":"de Vries BM et al. Explainable artificial intelligence (XAI) in radiology and nuclear medicine: A literature review. Front. Med. 10, 1180773 (2023).","journal-title":"Front. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52394-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52394-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:02:08Z","timestamp":1784026928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52394-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52394"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52394-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21876"}}